[ Price : $8.95]
Insulet Corp. recalls 400,000 units of its OmniPod (Pod) Insulin Management System, citing the possibility that some devices may h...[ Price : $8.95]
FDA tells uniQure that it will need to conduct more than one additional study to support a BLA submission for Glybera (alipogene t...[ Price : $8.95]
FDA requires a warning on all diabetes-treating dipeptidyl peptidase-4 (DPP-4) inhibitors because they may cause joint pain that c...[ Price : $8.95]
FDA accepts for review a Telesta Therapeutics BLA for MCNA for treating bladder cancer.[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance: Nonproprietary Naming of Biological Products.[ Price : $8.95]
Federal Register Notice: FDA releases a guidance: Determination of the Period Covered by a No-Tobacco-Sale Order (NTSO) and Compli...[ Price : $8.95]
Federal Register Proposed rule: FDA proposes to designate official names and proper names for certain biological products includin...[ Price : $8.95]
FDA approves a Sunovion Pharmaceuticals supplemental NDA for Aptiom (eslicarbazepine acetate) as monotherapy for treating partial-...